CFO Garry Lowenthal Receives 79,375 Restricted Shares in PetVivo

Rhea-AI Filing Summary

Garry Lowenthal, Chief Financial Officer of PetVivo Holdings, Inc., received a grant of restricted common stock on 09/18/2025 as compensation for past performance. The grant consisted of 79,375 shares at a stated price of $0.76 and was issued to a corporation owned by Mr. Lowenthal. After the reported transaction, the reporting persons indirect beneficial ownership totaled 592,967 shares. The Form 4 indicates this was a non-derivative award recorded as an acquisition and identifies the grant as compensation rather than a market purchase.

Positive

• Alignment of incentives: Grant of restricted stock ties CFO compensation to company equity performance.
• Increased insider ownership: Indirect beneficial ownership rose to 592,967 shares, signaling continued management stake.

Negative

• Potential dilution: Issuing 79,375 shares increases share count and may dilute existing shareholders.
• Limited disclosure: Form 4 does not provide vesting schedule, approval authority, or total shares outstanding to assess materiality.

Insights

Financial Analyst

TL;DR: Executive received a restricted-stock compensation grant of 79,375 shares, modestly increasing indirect ownership.

The grant is a standard compensation mechanism tying the CFOs interests to equity performance. The transaction is non-derivative and was issued to an entity controlled by the reporting person, which preserves potential alignment with shareholders while concentrating ownership indirectly. With an acquisition price of $0.76 per share disclosed on the form, the immediate market impact is likely minimal unless this grant size represents a material portion of outstanding shares; the form does not state total shares outstanding so materiality cannot be assessed from this filing alone.

Corporate Governance Expert

TL;DR: Compensation grant to a related entity is routine but should be disclosed clearly for governance transparency.

The filing clearly identifies the award as restricted common stock issued to a corporation owned by the reporting person as compensation for past performance, which is an acceptable practice when approved by the board or compensation committee. The indirect ownership disclosure is appropriate; however, the Form 4 does not include information about grant approval authority, vesting terms, or potential acceleration, which are relevant governance details for assessing incentives and alignment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LOWENTHAL GARRY N

(Last) (First) (Middle)

5151 EDINA INDUSTRIAL BLVD., SUITE 575

(Street)

EDINA, MN 55439

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PetVivo Holdings, Inc. [ PETV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/18/2025		A		79,375(1)	A	$0.76	592,967	I	By Corporation

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted common stock to a corporation owned by the Reporting Person as compensation for the Reporting Person's past performance.

	/s/ Garry Lowenthal	09/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did PetVivo (PETVW) report on this Form 4?

The Form 4 reports an acquisition of 79,375 shares of common stock on 09/18/2025 recorded as a grant of restricted stock to a corporation owned by the reporting person.

Who is the reporting person on the Form 4 for PetVivo (PETVW)?

The reporting person is Garry Lowenthal, who is identified as the Chief Financial Officer of PetVivo Holdings, Inc.

How many shares does the reporting person beneficially own after the transaction?

Following the reported acquisition, the reporting person holds 592,967 shares of common stock indirectly.

At what price were the shares in the grant recorded?

The grant is recorded at a price of $0.76 per share on the Form 4.

Was the grant described as compensation or a market purchase?

The Form 4 states the grant represents restricted common stock issued as compensation for past performance to a corporation owned by the reporting person.